<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01134406</url>
  </required_header>
  <id_info>
    <org_study_id>COR 1.0</org_study_id>
    <nct_id>NCT01134406</nct_id>
  </id_info>
  <brief_title>Hydros Joint Therapy and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis (OA)</brief_title>
  <official_title>A Prospective, Multi-center, Randomized, Double-blind Feasibility Study to Evaluate the Safety and Performance of Hydros Joint Therapy and Hydros-TA Joint Therapy for Management of Pain Associated With Osteoarthritis in the Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carbylan Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carbylan Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and performance of Hydros Joint Therapy
      (Hydros) and Hydros-TA Joint Therapy (Hydros-TA) for treatment of pain from osteoarthritis of
      the knee, in patients who have failed to respond adequately to conservative non-pharmacologic
      therapy and simple analgesics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to evaluate Hydros and Hydros-TA treated subject for reduction
      of osteoarthritis symptoms, compared to a commercial control, as assessed by the WOMAC
      Osteoarthritis Index.

      The WOMAC Osteoarthritis Index is a validated assessment instrument that is self-administered
      and designed to subjectively elicit patient symptoms of osteoarthritis in the knee in the
      areas of pain, stiffness, and physical function. The WOMAC Osteoarthritis Index with its Pain
      Subscale has been used extensively as an effectiveness endpoint in clinical trials of
      viscosupplements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>WOMAC VAS Pain over 26 weeks</measure>
    <time_frame>26 weeks post treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>WOMAC VAS Stiffness and Function over 26 weeks</measure>
    <time_frame>26 weeks post treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Osteoarthritis of the Knee</condition>
  <arm_group>
    <arm_group_label>Hydros Joint Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental viscosupplement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydros-TA Joint Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental viscosupplement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Synvisc-One</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Commercial control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hydros Joint Therapy</intervention_name>
    <description>Single intra-articular injection.</description>
    <arm_group_label>Hydros Joint Therapy</arm_group_label>
    <other_name>Hydros</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hydros-TA Joint Therapy</intervention_name>
    <description>Single intra-articular injection</description>
    <arm_group_label>Hydros-TA Joint Therapy</arm_group_label>
    <other_name>Hydros-TA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Synvisc-One</intervention_name>
    <description>Single intra-articular injection.</description>
    <arm_group_label>Synvisc-One</arm_group_label>
    <other_name>Hylan G-F 20</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Osteoarthritis grade 2 or 3 in one knee using Kellgren-Lawrence Grading for OA
        radiologically and verified within the prior 6 months.

        Exclusion Criteria:

          -  Secondary OA resulting from rheumatoid arthritis, chondrocalcinosis, osteonecrosis,
             chronic fibromyalgia or other autoimmune disease.

          -  Generalized symptomatic OA in lower extremity joints other than the knees.

          -  Active infection in either knee joint or adjacent tissues.

          -  Any contraindications for intra-articular injection or aspiration.

          -  Knee surgery or trauma within 3 months prior to enrollment.

          -  Intra-articular steroid injection in the knee and/or use of systemic (oral)
             corticosteroids within 3 months prior to enrollment.

          -  Intra-articular hyaluronan injection in the treatment knee within 6 months prior to
             enrollment.

          -  Body Mass Index (BMI) greater than 35.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>London Health Sciences Centre Research</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2010</study_first_submitted>
  <study_first_submitted_qc>May 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2010</study_first_posted>
  <last_update_submitted>November 2, 2011</last_update_submitted>
  <last_update_submitted_qc>November 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>knee</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hylan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

